SPBP35G2.11c Antibody

What is SPBP35G2.11c and what is its role in fission yeast?

SPBP35G2.11c (UniProt: Q9P792) is a protein found in Schizosaccharomyces pombe (fission yeast), specifically in strain 972 / ATCC 24843. While the precise function of this protein has not been fully characterized in the provided literature, S. pombe serves as an important model organism for studying fundamental cellular processes. Based on research involving S. pombe proteins, SPBP35G2.11c may play a role in cellular regulation pathways. Studies on fission yeast have identified various proteins involved in key cellular mechanisms including cell cycle regulation, stress responses, and signaling pathways like those involving TSC1 and TSC2 homologs, which control fundamental processes like cell growth . Further characterization of SPBP35G2.11c would likely involve genetic manipulation experiments and protein interaction studies using specific antibodies against this target.

What applications is the SPBP35G2.11c antibody validated for?

The rabbit polyclonal SPBP35G2.11c antibody has been validated for specific research applications including:

• ELISA (Enzyme-Linked Immunosorbent Assay) - For quantitative detection of the target protein in samples

• Western Blot (WB) - For detection of denatured protein by molecular weight separation

These validated applications make this antibody suitable for protein expression analysis, particularly in experiments involving S. pombe. The antibody has undergone affinity purification against the recombinant immunogen, which enhances its specificity for the target protein. Each validation method would require different optimization parameters, including dilution factors, incubation conditions, and detection systems appropriate to the technique being employed.

What components are included with the SPBP35G2.11c antibody package?

The commercial SPBP35G2.11c antibody package typically contains three essential components that support comprehensive experimental design:

These components allow researchers to perform complete validation studies by comparing specific binding (using the antibody) against background signals (using pre-immune serum) and confirming target identity (using the antigen as positive control) . This comprehensive package facilitates rigorous experimental design with appropriate controls, which is essential for producing reliable and reproducible research data.

How should I optimize Western blot protocols when using SPBP35G2.11c antibody?

Western blot optimization with SPBP35G2.11c antibody requires careful consideration of several parameters:

When troubleshooting, systematically modify one parameter at a time while keeping others constant, which will help identify the optimal conditions for your specific experimental system.

What are the key considerations for designing immunoprecipitation experiments with SPBP35G2.11c antibody?

Immunoprecipitation (IP) with SPBP35G2.11c antibody requires careful consideration of several factors:

• Lysis buffer selection: For yeast proteins, use buffers containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% NP-40 or Triton X-100, and protease inhibitor cocktail. If studying protein-protein interactions, gentler detergents like digitonin (0.5-1%) may better preserve complexes.

• Pre-clearing strategy: Pre-clear lysates with protein A/G beads to reduce non-specific binding, which is particularly important when working with polyclonal antibodies.

• Antibody coupling: For improved results, consider covalently coupling the antibody to beads using crosslinkers like dimethyl pimelimidate (DMP) to prevent antibody leaching during elution.

• IP validation: Use the provided pre-immune serum as a negative control IP to identify non-specific binding . Additionally, perform a reciprocal IP with antibodies against suspected interaction partners when studying protein complexes.

• Target verification: Confirm successful IP by probing a small fraction of the immunoprecipitate with the antibody via Western blot. If studying novel interactions, consider mass spectrometry analysis of immunoprecipitated complexes, similar to the approaches used in TTT complex studies .

When optimizing IP protocols, consider that native protein conformation may affect epitope accessibility, so adjusting detergent types and concentrations can significantly impact success rates.

How can I use SPBP35G2.11c antibody to study protein farnesylation in relation to S. pombe cellular pathways?

SPBP35G2.11c antibody can be leveraged to investigate protein farnesylation pathways in S. pombe through several strategic approaches:

• Co-immunoprecipitation studies: Using the SPBP35G2.11c antibody to immunoprecipitate the target protein, analyze whether it interacts with components of the farnesylation machinery, such as the β-subunit of farnesyltransferase (encoded by cpp1+ in S. pombe) . This approach could reveal whether SPBP35G2.11c is involved in farnesylation pathways.

• Comparative protein expression analysis: Perform Western blot analysis using SPBP35G2.11c antibody on samples from wild-type yeast and farnesylation-deficient mutants (e.g., cpp1-1) to determine if farnesylation affects SPBP35G2.11c expression levels or post-translational modifications .

• Subcellular localization studies: Use the antibody in immunofluorescence microscopy to track whether SPBP35G2.11c localization changes in farnesylation-deficient backgrounds, which could indicate functional relationships with farnesylated proteins like Rhb1.

• Functional studies coupling genetic and immunological approaches: Combine genetic manipulation (e.g., cpp1-1 mutation) with immunoblotting using SPBP35G2.11c antibody to analyze how disruption of protein farnesylation affects SPBP35G2.11c in the context of cellular signaling pathways, particularly those involving Tsc1/Tsc2 homologs .

When designing these experiments, consider that protein farnesylation affects membrane localization and protein-protein interactions, so cellular fractionation prior to immunoblotting may provide additional insights into the functional significance of SPBP35G2.11c.

What are the most effective troubleshooting approaches for non-specific binding when using SPBP35G2.11c antibody?

When encountering non-specific binding with SPBP35G2.11c antibody, implement these systematic troubleshooting strategies:

• Titrate antibody concentration: Non-specific binding often results from excessive antibody concentration. Perform a dilution series (1:500, 1:1000, 1:2000, 1:5000) to identify the optimal concentration that maximizes specific signal while minimizing background.

• Modify blocking conditions: If milk-based blocking buffers yield high background, switch to alternative blocking agents:

  • 3-5% BSA in TBST

  • Commercial blocking reagents specifically designed for yeast applications

  • Fish gelatin (2-3%) which can reduce background in certain applications

• Increase washing stringency: Implement additional or longer washing steps with higher stringency buffers (increase Tween-20 concentration to 0.2-0.3% or add 0.1% SDS to washing buffer).

• Pre-adsorb the antibody: Incubate the diluted antibody with the pre-immune serum provided in the kit at a 1:10 ratio for 1 hour at room temperature before applying to the membrane/samples.

• Validate with controls: Always run parallel experiments using:

  • The provided pre-immune serum as a negative control

  • The provided antigen as a positive control

  • If available, samples from knockout strains lacking SPBP35G2.11c

• Cross-adsorption against related species proteins: If cross-reactivity with related proteins is suspected, pre-adsorb the antibody against lysates from closely related species that lack the specific target.

Document all optimization steps systematically to establish a reproducible protocol for your specific experimental system.

How do I determine the appropriate dilution factors for SPBP35G2.11c antibody across different applications?

Determining optimal dilution factors for SPBP35G2.11c antibody requires application-specific titration:

For Western blotting:

• Prepare a dilution series (1:500, 1:1000, 1:2000, 1:5000) using the same sample

• Process identically except for antibody concentration

• Evaluate signal-to-noise ratio at each dilution

• Select the dilution that provides clear specific bands with minimal background

For ELISA applications:

• Create an antibody dilution matrix (1:500 to 1:10,000) against an antigen concentration gradient

• Generate a titration curve for each dilution

• Calculate the EC50 (half-maximal effective concentration) for each curve

• Select the dilution providing the steepest slope in the linear range of detection with minimal background

For immunofluorescence (if applicable):

• Test dilutions ranging from 1:100 to 1:1000

• Include appropriate negative controls (pre-immune serum )

• Select the dilution providing specific signal with minimal background autofluorescence

For immunoprecipitation:

• Start with 2-5 μg antibody per 500 μg total protein

• Compare efficiency against higher (10 μg) and lower (1 μg) amounts

• Select the minimum antibody concentration that efficiently precipitates the target

Document optimal dilutions in your laboratory protocols to ensure reproducibility across experiments and between researchers.

What are the critical factors affecting reproducibility when using SPBP35G2.11c antibody in quantitative assays?

Ensuring reproducibility with SPBP35G2.11c antibody in quantitative assays requires controlling multiple variables:

• Antibody storage and handling:

  • Store according to manufacturer specifications (-20°C or -80°C)

  • Avoid repeated freeze-thaw cycles (aliquot upon first thaw)

  • Record lot numbers and validate new lots against previous results

• Sample preparation standardization:

  • Use consistent cell lysis protocols

  • Standardize protein quantification methods

  • Process all experimental samples simultaneously

• Technical replication design:

  • Include technical triplicates for ELISA applications

  • For Western blots, normalize to loading controls (e.g., actin, GAPDH)

  • Generate standard curves with purified antigen for absolute quantification

• Assay condition standardization:

  • Maintain consistent incubation times and temperatures

  • Use automated pipetting when possible

  • Control environmental factors (temperature, humidity)

• Validation controls:

  • Include positive controls (provided antigen)

  • Incorporate negative controls (pre-immune serum)

  • Use biological reference standards when available

• Data analysis protocols:

  • Establish standard analysis workflows

  • Use consistent background subtraction methods

  • Apply appropriate statistical tests based on data distribution

• Equipment calibration:

  • Regularly calibrate plate readers for ELISA

  • Standardize imaging settings for Western blot densitometry

By systematically controlling these variables, researchers can significantly improve the reproducibility of quantitative assays using SPBP35G2.11c antibody across different experiments and between laboratory members.

How can SPBP35G2.11c antibody be used to investigate protein-protein interactions in the context of Tsc1/Tsc2 signaling in S. pombe?

SPBP35G2.11c antibody can be strategically employed to investigate protein-protein interactions within the Tsc1/Tsc2 signaling network through several advanced approaches:

• Co-immunoprecipitation coupled with mass spectrometry:

  • Immunoprecipitate SPBP35G2.11c from S. pombe lysates using the antibody

  • Analyze precipitated complexes via LC-MS/MS to identify interacting partners

  • Compare interactome profiles between wild-type and tsc1Δ/tsc2Δ backgrounds to identify Tsc1/Tsc2-dependent interactions

• Proximity-dependent labeling:

  • Generate fusion constructs of SPBP35G2.11c with BioID or APEX2

  • Validate expression and functionality using the SPBP35G2.11c antibody

  • Identify proximal proteins through streptavidin pulldown and mass spectrometry

  • Compare proximity profiles between normal and nutrient-starved conditions, as Tsc1/Tsc2 are known to respond to nutrient signaling

• Sequential immunoprecipitation (tandem IP):

  • Perform first IP with SPBP35G2.11c antibody

  • Elute under native conditions

  • Perform second IP with antibodies against components of the Tsc1/Tsc2 pathway

  • This approach can identify specific subcomplexes containing both SPBP35G2.11c and Tsc1/Tsc2 components

• In situ proximity ligation assay:

  • Use SPBP35G2.11c antibody together with antibodies against Tsc1/Tsc2 pathway components

  • Detect protein-protein interactions in fixed cells with spatial resolution

  • Compare interaction patterns between wild-type and mutant strains

These approaches can provide insights into whether SPBP35G2.11c functions within or parallel to the Tsc1/Tsc2 signaling network, which regulates fundamental processes like cell growth and response to nutrient conditions in S. pombe .

What strategies can be employed to study the potential role of SPBP35G2.11c in translation and protein maturation pathways?

Investigating SPBP35G2.11c's potential role in translation and protein maturation can be approached using these advanced strategies:

• Polysome profiling with immunodetection:

  • Fractionate S. pombe lysates on sucrose gradients to separate free ribosomes from polysomes

  • Analyze fractions by Western blot using SPBP35G2.11c antibody

  • Determine whether SPBP35G2.11c associates with actively translating ribosomes, similar to analyses performed with TTT complex components

• Ribosome profiling coupled with SPBP35G2.11c immunoprecipitation:

  • Perform SPBP35G2.11c IP under conditions that preserve ribosome association

  • Extract and sequence ribosome-protected mRNA fragments

  • Identify specific mRNAs being translated when associated with SPBP35G2.11c

• Pulse-chase analysis of protein maturation:

  • Metabolically label nascent proteins in S. pombe

  • Immunoprecipitate specific proteins of interest at various chase timepoints

  • Determine whether SPBP35G2.11c antibody co-precipitates these proteins during maturation

  • Compare maturation kinetics between wild-type and SPBP35G2.11c-depleted cells

• Proximity-based biotinylation of nascent chains:

  • Adapt methods similar to those used to study TTT complex interactions with nascent PIKK kinases

  • Determine if SPBP35G2.11c associates with specific nascent polypeptides

  • Validate interactions using the SPBP35G2.11c antibody

• Proteomic analysis of cotranslational complexes:

  • Perform selective ribosome profiling in SPBP35G2.11c-tagged strains

  • Identify mRNAs specifically associated with SPBP35G2.11c during translation

  • Validate findings using SPBP35G2.11c antibody in Western blots

These approaches can reveal whether SPBP35G2.11c functions similarly to chaperones like the TTT complex, which promotes cotranslational maturation of certain kinases prior to complex assembly .

How can SPBP35G2.11c antibody be utilized in investigating the relationship between protein farnesylation and stress response pathways?

To investigate the intersection between protein farnesylation and stress response pathways using SPBP35G2.11c antibody, implement these advanced research approaches:

• Comparative phosphoproteomics:

  • Expose wild-type and farnesylation-deficient (cpp1-1) S. pombe strains to various stressors (oxidative, nutritional, temperature)

  • Immunoprecipitate SPBP35G2.11c using the specific antibody

  • Analyze phosphorylation patterns via mass spectrometry

  • Identify stress-responsive phosphorylation events that depend on functional farnesylation

• Chromatin immunoprecipitation (ChIP) analysis:

  • If SPBP35G2.11c has nuclear functions, perform ChIP using the antibody

  • Compare binding patterns between wild-type and farnesylation-deficient backgrounds

  • Correlate with gene expression changes observed in tsc1Δ/tsc2Δ strains during nitrogen starvation

  • Identify genes potentially regulated by SPBP35G2.11c in a farnesylation-dependent manner

• Quantitative microscopy with subcellular fractionation:

  • Perform immunofluorescence with SPBP35G2.11c antibody under various stress conditions

  • Compare localization patterns between wild-type and cpp1-1 mutants

  • Correlate with biochemical fractionation followed by Western blotting

  • Determine if stress-induced relocalization depends on farnesylation status

• Temporal dynamics analysis:

  • Subject cells to stress time courses (e.g., nitrogen starvation)

  • Monitor SPBP35G2.11c levels, modification state, and localization using the antibody

  • Compare dynamics between wild-type and farnesylation-deficient backgrounds

  • Correlate with induction kinetics of stress-responsive genes like retrotransposons, cyclins, and permeases

• Genetic interaction mapping:

  • Create double mutants between SPBP35G2.11c deletion and farnesylation pathway components

  • Analyze phenotypes under stress conditions

  • Use the antibody to validate protein expression in complementation studies

  • Determine epistatic relationships between SPBP35G2.11c and farnesylation pathways

These approaches can reveal whether SPBP35G2.11c functions in stress response pathways that interact with protein farnesylation mechanisms, potentially opening new avenues for understanding fundamental cellular adaptation processes.

How should researchers quantify and statistically analyze Western blot data generated using SPBP35G2.11c antibody?

Proper quantification and statistical analysis of Western blot data using SPBP35G2.11c antibody requires rigorous methodology:

• Image acquisition optimization:

  • Capture images within the linear dynamic range of the detection system

  • Avoid saturated pixels that compromise quantification

  • Include a dilution series of a reference sample to confirm linear response

• Densitometric analysis protocol:

  • Use dedicated software (ImageJ, Image Lab, etc.) for consistent analysis

  • Define measurement areas of consistent size across all bands

  • Subtract local background using adjacent areas with no signal

  • Normalize target protein to appropriate loading controls

• Normalization strategy selection:

  • For total protein normalization, use Ponceau S or SYPRO Ruby staining of the entire lane

  • For housekeeping protein normalization, select proteins with stable expression under your experimental conditions

  • Consider using the Total Protein Normalization (TPN) method for more accurate quantification

• Statistical analysis approach:

  • For comparing two conditions: Student's t-test (parametric) or Mann-Whitney U test (non-parametric)

  • For multiple conditions: ANOVA with appropriate post-hoc tests (Tukey's, Dunnett's)

  • For non-normally distributed data: Apply appropriate transformations or use non-parametric tests

  • Present data as mean ± standard deviation or standard error based on at least three biological replicates

• Data presentation standards:

  • Include representative blot images alongside quantification graphs

  • Present full blots in supplementary materials to demonstrate specificity

  • Indicate sample size (n) and p-values for statistical significance

  • Use consistent y-axis scales when comparing across multiple experiments

Following these guidelines ensures that quantitative data derived from Western blots using SPBP35G2.11c antibody will be robust, reproducible, and statistically sound, meeting the standards expected in high-quality research publications.

What approaches should be used to validate the specificity of SPBP35G2.11c antibody against potential cross-reactivity with related proteins?

Validating SPBP35G2.11c antibody specificity requires a multi-faceted approach to conclusively rule out cross-reactivity:

• Genetic validation strategies:

  • Compare immunoblotting results between wild-type and SPBP35G2.11c deletion strains

  • Test antibody reactivity in strains with epitope-tagged SPBP35G2.11c

  • Perform complementation studies with mutated versions of SPBP35G2.11c and assess antibody recognition

• Competitive binding assays:

  • Pre-incubate the antibody with excess purified antigen (provided in the kit)

  • Compare signal intensity with and without competitive binding

  • Specific antibodies will show significant signal reduction after pre-incubation

• Cross-species reactivity assessment:

  • Test antibody against lysates from different yeast species with varying degrees of homology

  • Analyze correlation between sequence conservation and antibody reactivity

  • This approach helps identify potential cross-reactive epitopes

• Mass spectrometry validation:

  • Immunoprecipitate with SPBP35G2.11c antibody and analyze by mass spectrometry

  • Compare identified proteins with theoretical SPBP35G2.11c sequence

  • Identify potential cross-reactive proteins for further validation

• Epitope mapping:

  • Generate a panel of truncated SPBP35G2.11c constructs

  • Test antibody reactivity against each construct

  • Identify the specific epitope(s) recognized by the antibody

  • Compare with sequence homology in related proteins

• Controls implementation:

  • Always include the provided pre-immune serum as a negative control

  • Use the provided antigen as a positive control

  • Include technical controls (secondary antibody only, isotype control)

These validation approaches provide complementary evidence for antibody specificity, strengthening the reliability of research findings and increasing confidence in the interpretation of experimental results using SPBP35G2.11c antibody.

How can researchers integrate SPBP35G2.11c antibody data with genomic and transcriptomic datasets to gain comprehensive biological insights?

Integrating SPBP35G2.11c antibody-generated protein data with genomic and transcriptomic datasets requires sophisticated multi-omics approaches:

• Correlation analysis between protein and mRNA levels:

  • Quantify SPBP35G2.11c protein levels using the antibody across different conditions

  • Correlate with SPBP35G2.11c mRNA expression from RNA-seq or microarray data

  • Identify conditions where post-transcriptional regulation may occur

  • Compare with patterns observed for other genes in the Tsc1/Tsc2 pathway

• ChIP-seq integration with proteomics:

  • If SPBP35G2.11c has DNA-binding properties, perform ChIP-seq using the antibody

  • Correlate binding sites with gene expression changes in relevant conditions

  • Integrate with proteomics data to create protein-DNA interaction networks

  • Analyze in the context of stress response pathways affected by nitrogen starvation

• Pathway enrichment analysis:

  • Identify proteins co-immunoprecipitated with SPBP35G2.11c antibody

  • Perform pathway enrichment analysis on this interactome

  • Correlate with differentially expressed genes under matching conditions

  • Identify pathways where SPBP35G2.11c may serve as a connector between transcriptional and post-transcriptional regulation

• Time-course multi-omics integration:

  • During responses like nitrogen starvation, collect time-series data for:

    • SPBP35G2.11c protein levels/modifications (using the antibody)

    • Transcriptome changes (RNA-seq)

    • Chromatin state alterations (ATAC-seq or similar)

  • Apply time-lagged correlation analysis to infer causality

  • Model the temporal sequence of events in relevant pathways

• Network analysis with farnesylation-dependent interactions:

  • Compare SPBP35G2.11c interaction networks between wild-type and cpp1-1 mutants

  • Overlay with transcriptome changes in the same genetic backgrounds

  • Identify nodes where protein farnesylation affects both physical interactions and gene expression

  • Model how SPBP35G2.11c fits within these networks

• Data visualization strategies:

  • Create integrated heatmaps showing protein, transcript, and interaction data

  • Develop network visualizations highlighting SPBP35G2.11c connections

  • Use dimensionality reduction techniques (PCA, t-SNE) to identify patterns across multi-omics datasets